skip to main content
React to this bill with an emoji:
Save your position on this bill bill on a six-point scale from strongly oppose to strongly support:

S. 1899: Community Health Investment, Modernization, and Excellence Act of 2017

The text of the bill below is as of Sep 28, 2017 (Introduced).

II

115th CONGRESS

1st Session

S. 1899

IN THE SENATE OF THE UNITED STATES

September 28, 2017

(for himself, Ms. Stabenow, Mrs. Capito, Mr. Carper, Mr. Gardner, Mr. Cardin, Ms. Collins, Mrs. McCaskill, Mr. Wicker, and Mr. Manchin) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To reauthorize and extend funding for community health centers and the National Health Service Corps.

1.

Short title

This Act may be cited as the Community Health Investment, Modernization, and Excellence Act of 2017.

2.

Extension of funding for community health centers and National Health Service Corps

Section 221 of the Medicare Access and CHIP Reauthorization Act of 2015 is amended—

(1)

in subsection (a), by adding at the end the following:

(3)

Additional funding

In addition to amounts appropriated under section 10503(b) of the Patient Protection and Affordable Care Act, there are appropriated to the CHC Fund the following:

(A)

For purposes of paragraph (1) of such section—

(i)

for fiscal year 2018, $3,600,000,000;

(ii)

for fiscal year 2019, $3,800,000,000;

(iii)

for fiscal year 2020, $4,000,000,000;

(iv)

for fiscal year 2021, $4,200,000,000; and

(v)

for fiscal year 2022, $4,400,000,000.

(B)

For purposes of paragraph (2) of such section—

(i)

$310,000,000 for fiscal year 2018;

(ii)

$325,000,000 for fiscal year 2019;

(iii)

$340,000,000 for fiscal year 2020;

(iv)

$355,000,000 for fiscal year 2021; and

(v)

$370,000,000 for fiscal year 2022.

; and

(2)

in subsection (c), by striking and fiscal year 2107 and inserting , fiscal year 2017, fiscal year 2018, fiscal year 2019, fiscal year 2020, fiscal year 2021, and fiscal year 2022.